Intra Cellular Therapies | Crediti Commerciali



Trade Debtors Cambiamento Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
ALKERMES USD 394.72M 24.54M 2024-12
Biogen USD 1.87B 119.3M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
Gilead Sciences USD 4.42B 167M 2024-12
Halozyme Therapeutics USD 308.46M 22.71M 2024-12
Intra Cellular Therapies USD 166.5M 20.89M 2024-12
J&J USD 14.84B 1.33B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 7.56B 594M 2024-12
Prothena USD 0 0 2024-12
RedHill Biopharma USD 974K 0 2024-06
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
United Therapeutics USD 279.3M 62.5M 2024-12



Intra Cellular Therapies Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.